Mean female age at first birth has increased steadily over the past few decades in many developed countries. This postponement leads to couples attempting to have children during a period where female fertility is already in decline.
Anti-Müllerian hormone (AMH)
AMH is a direct serum marker of functional ovarian reserve and plays an important role in assessing ovarian reserve levels.1,2
AMH is a reliable marker for the assessment of the ovarian reserve in conjunction with other clinical and laboratory findings before starting any fertility therapy.
About the Elecsys® AMH assay
As the first fully automated AMH assay cleared by the FDA, the Elecsys® AMH assay is designed for use on all Roche immunoassay systems for low-, mid- and high-volume testing environments, including the cobas® e 411, cobas® e 601, cobas® e 602, and cobas® e 801 analyzers.
Other key features of the assay include*:
- Fully automated, sensitive and robust measurement of AMH3
- High precision over entire measuring range for reliable results3
- Clinical agreement with Antral-Follicle-Count (AFC)4
- 18 min. run time and same-day result reporting on in-house testing3
- Low sample volume; as low as 30 μL3
- Age-specific reference ranges3
- Up to 112 days (16 weeks) onboard stability3